Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3155069b833b184bcd4ad12f7100dd4c |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4703 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
filingDate |
2014-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2017-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d69769575cb9f92cf67a18e510de263 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c9a7559f47426cb353a1bc16efff7bc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_068c4c4af90342b0038b97ecfe18060a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_743b58d86402d176586eb8fcdb9cc5a1 |
publicationDate |
2017-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-9683025-B2 |
titleOfInvention |
Methods and compositions for treating cancer and inflammatory diseases |
abstract |
The invention provides a peptide construct comprising a cell penetrating peptide and an inhibitory peptide that interferes with the interaction between E1A and CtBP. The invention also provides related pharmaceutical composition comprising such a peptide construct. Also provided is a conjugate comprising such a peptide construct and a carrier molecule. The invention also provides related pharmaceutical compositions. Also provided are related methods of inhibiting cell proliferation in an individual and methods of treating cancer in by such pharmaceutical compositions. The present application also provides methods of treating an inflammatory disease and inhibiting inflammation in an individual comprising administering to the individual an effective amount of a therapeutic agent comprising an inhibitory peptide that interferes with the interaction between E1A and CtBP. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11746334-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2782528-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11485767-B2 |
priorityDate |
2013-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |